Identifying and Caring for Individuals With Inherited Cancer Syndrome

NCT04494945 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27500

Last updated 2026-01-23

No results posted yet for this study

Summary

This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general public. Researchers hope to learn the value of providing broad, public-wide testing for high risk cancer types (like hereditary breast and ovarian cancer or Lynch syndromes) instead of only testing people whose families are known to be high risk.

Conditions

  • BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
  • Breast Ductal Carcinoma In Situ
  • Hematopoietic and Lymphoid System Neoplasm
  • Hereditary Neoplastic Syndrome
  • Lynch Syndrome
  • Malignant Solid Neoplasm

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of saliva sample

OTHER

Genetic Counseling

Receive genetic counseling if testing results are positive

OTHER

Genetic Testing

Undergo genetic testing

OTHER

Survey Administration

Complete a survey

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Oregon Health and Science University

    collaborator OTHER
  • OHSU Knight Cancer Institute

    lead OTHER

Principal Investigators

  • Jackilen Shannon, Ph.D. · OHSU Knight Cancer Institute

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-09
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04494945 on ClinicalTrials.gov